We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0285
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.003 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0285
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unsecured Loan Facility for £1,000,000

4 May 2021 07:00

RNS Number : 3336X
Dukemount Capital PLC
04 May 2021
 

Dukemount Capital PLC

04 May 2021

 

 

 

Dukemount Capital Plc

("Dukemount" or the "Company")

 Unsecured Loan Facility Signed for £1,000,000

 

 

Dukemount Capital Plc ("Dukemount" or the "Company"), the property management company and long dated income specialist, continues to assess long dated income opportunities, which it believes could be material to the Company. On 22 March 2021, Dukemount announced that it had agreed outline terms for a joint venture with HSKB, a company with a very experienced environmental energy team and which is involved in the flexibility power sector. The joint venture is targeting Capacity Market contracts for two 11KV gas peaking sites which will secure CPI-linked long-dated income.

 

In order to take advantage of this opportunity, on 1 May 2021, the Company entered into a 12-month convertible unsecured loan facility for £1,000,000 ("Facility") with a consortium arranged by Sanderson Capital Partners Limited the ("Lenders"), of which £500,000 is available immediately and the additional £500,000 available conditional on certain milestones being met by the Company.

 

The interest free unsecured convertible Facility will provide the initial funding from Dukemount to the joint venture. An availability fee of £70,000 is payable in Dukemount shares, at a deemed issue price of £0.0071 per share. Each drawdown on the facility is subject to a 2% fee payable in shares at a deemed issue price of £0.0071 per share. In addition, the Lenders have been issued warrants which are convertible at an exercise price of £0.00715 for a period of 2 years from the date of execution of the Warrant Instrument. The Facility is convertible at the election of the Company or the Lenders into ordinary shares at a deemed issued price of £0.0065 per share, subject to the Company having sufficient authorities in place and to the publication of any prospectus required pursuant to the Prospectus Regulation Rules.

 

Matthew Thompson, Chief Executive Officer said: " The management of Dukemount remain committed to providing investors with long-dated income opportunities.

 

We are very pleased to have partnered with HSKB, who are compliant with current ESG guidelines and legislation and run by an experienced team in the environmental energy and gas peaking space. We see great potential in this fast-growing industry providing the long-dated income opportunities investors require and believe this facility agreement is a vote of confidence in the project and the management team. We look forward to updating shareholders further with news as and when appropriate."

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018).

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc

Via St Swithins PR

Geoffrey Dart / Matthew Thompson

St Swithins PR (Media and Investor Enquiries)

Tel: +44 (0) 1732 521132

Gary Middleton

gary@swithins.com

Peterhouse Capital Limited

Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBXLLBFELFBBX
Date   Source Headline
18th Apr 20243:09 pmRNSResult of AGM
21st Mar 20247:00 amRNSNotice of AGM and a conditional subscription
8th Mar 20244:29 pmRNSTR-1: Standard form notification of major holdings
7th Mar 202410:51 amRNSUpdate on the Facility Agreement and TVR
5th Mar 202412:45 pmRNSHolding(s) in Company
4th Mar 20241:16 pmRNSCapitalisation of Loan, Issue of Equity & Warrants
26th Feb 202410:04 amRNSHolding(s) in Company
30th Jan 202412:09 pmRNSFinal Results
12th Jan 20242:13 pmRNSResult of AGM
14th Dec 20239:56 amRNSNotice of AGM
12th Sep 20237:44 amRNSProposed lifting of suspension and other updates
16th Jun 20237:00 amRNSHalf-year Report
9th Jun 202310:17 amRNSFinal Results
22nd Nov 20227:06 amRNSChange of Broker
1st Nov 20228:03 amRNSTemporary Suspension
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20229:32 amRNSIssue of Equity
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20229:32 amRNSIssue of Equity
20th Oct 20229:26 amRNSIssue of Equity
19th Oct 202212:33 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20222:05 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
12th Oct 20227:00 amRNSIssue of Equity
11th Oct 20227:00 amRNSFurther Funding and Funding Restructuring
5th Oct 20229:05 amRNSSecond Price Monitoring Extn
5th Oct 20229:00 amRNSPrice Monitoring Extension
5th Oct 20227:20 amRNSCompletion of sale
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20221:43 pmRNSInterim Results
4th Jan 20224:36 pmRNSHolding(s) in Company
29th Oct 20212:16 pmRNSFinal Results
7th Oct 202110:08 amRNSChange of Broker
4th Oct 20217:19 amRNSCompletion of Purchase of Energy Generation Sites
27th Sep 202110:44 amRNSHolding(s) in Company
15th Sep 20217:32 amRNSCompletion of Gas Peaking Funding
17th Aug 202110:55 amRNSHolding(s) in Company
10th Aug 202110:03 amRNSUpdate Re Funding
19th Jul 20217:00 amRNSHolding(s) in Company
19th Jul 20217:00 amRNSHolding(s) in Company
15th Jul 202111:19 amRNSResult of GM
30th Jun 20212:06 pmRNSSecond Price Monitoring Extn
30th Jun 20212:00 pmRNSPrice Monitoring Extension
29th Jun 20213:42 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.